OBSOLETE: Familial chondromalacia patellae

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1428
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Familial chondromalacia patellae is a rare inherited condition that affects the kneecap (patella). In this condition, the smooth cartilage on the underside of the kneecap softens and breaks down over time. This cartilage normally helps the kneecap glide smoothly over the knee joint during bending and straightening movements. When it deteriorates, it causes knee pain, stiffness, and a grinding or crackling sensation when moving the knee. The term 'familial' means this form runs in families, distinguishing it from the much more common non-inherited form of chondromalacia patellae (also called patellofemoral syndrome or 'runner's knee'). It is worth noting that this entry has been marked as 'OBSOLETE' in the Orphanet classification, meaning it may have been reclassified or merged with another condition. The familial form was historically described in families where multiple members across generations experienced early-onset softening of the kneecap cartilage. Treatment is generally focused on managing symptoms, including physical therapy to strengthen the muscles around the knee, pain management, activity modification, and in some cases surgical intervention. Patients should consult with an orthopedic specialist and a clinical geneticist to understand the specific nature of their condition and whether updated diagnostic classifications apply.

Key symptoms:

Knee pain, especially when climbing stairs or sitting for long periodsGrinding or crackling sensation in the knee when bendingSwelling around the kneecapStiffness in the knee jointPain that worsens with physical activityFeeling of the knee giving way or being unstableDifficulty kneeling or squattingTenderness around or behind the kneecapPain after prolonged sitting with bent knees

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Familial chondromalacia patellae.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Familial chondromalacia patellae at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Familial chondromalacia patellae community →

No specialists are currently listed for OBSOLETE: Familial chondromalacia patellae.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Familial chondromalacia patellae.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Familial chondromalacia patellaeForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Familial chondromalacia patellae.

Start the conversation →

Latest news about OBSOLETE: Familial chondromalacia patellae

No recent news articles for OBSOLETE: Familial chondromalacia patellae.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Is my condition truly familial, and should other family members be evaluated?,What specific exercises and physical therapy approaches are best for my situation?,Are there any new treatments or clinical trials for cartilage repair that I should know about?,How can I tell if my condition is getting worse, and when should I come back?,Should I see a geneticist to better understand the hereditary aspect of my condition?,What activities should I avoid, and what activities are safe for me?,At what point should I consider surgical options?

Common questions about OBSOLETE: Familial chondromalacia patellae

What is OBSOLETE: Familial chondromalacia patellae?

Familial chondromalacia patellae is a rare inherited condition that affects the kneecap (patella). In this condition, the smooth cartilage on the underside of the kneecap softens and breaks down over time. This cartilage normally helps the kneecap glide smoothly over the knee joint during bending and straightening movements. When it deteriorates, it causes knee pain, stiffness, and a grinding or crackling sensation when moving the knee. The term 'familial' means this form runs in families, distinguishing it from the much more common non-inherited form of chondromalacia patellae (also called pa

How is OBSOLETE: Familial chondromalacia patellae inherited?

OBSOLETE: Familial chondromalacia patellae follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.